Basics |
Exact Sciences Corporation
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
|
IPO Date: |
January 31, 2001 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$10.19B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.76 | 2.71%
|
Avg Daily Range (30 D): |
$0.85 | 1.90%
|
Avg Daily Range (90 D): |
$0.93 | 1.87%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.22M |
Avg Daily Volume (30 D): |
3.19M |
Avg Daily Volume (90 D): |
2.59M |
Trade Size |
Avg Trade Size (Sh.): |
101 |
Avg Trade Size (Sh.) (30 D): |
71 |
Avg Trade Size (Sh.) (90 D): |
67 |
Institutional Trades |
Total Inst.Trades: |
19,390 |
Avg Inst. Trade: |
$3.14M |
Avg Inst. Trade (30 D): |
$2.66M |
Avg Inst. Trade (90 D): |
$3.73M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
6 |
Market Closing Trades |
Avg Closing Trade: |
$10.26M |
Avg Closing Trade (30 D): |
$17.16M |
Avg Closing Trade (90 D): |
$24M |
Avg Closing Volume: |
178.22K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
|
$-.01
|
$-.54
|
Diluted EPS
|
|
$-.01
|
$-.54
|
Revenue
|
$
|
$ 811.09M
|
$ 706.79M
|
Gross Profit
|
$
|
$ 562.45M
|
$ 500.55M
|
Net Income / Loss
|
$
|
$ -1.19M
|
$ -101.22M
|
Operating Income / Loss
|
$
|
$ -2.15M
|
$ -96.01M
|
Cost of Revenue
|
$
|
$ 248.63M
|
$ 206.24M
|
Net Cash Flow
|
$
|
$ 309.97M
|
$ -259.51M
|
PE Ratio
|
|
|
|
|
|
|